Childhood Guillain-Barre syndrome: Clinical presentation, diagnosis, and therapy

Journal of Child Neurology

Volumn 11, Issue 1, 1996, Pages 4-12

  Jones Jr , H Royden ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; PREDNISONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROMYOGRAM; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SPINAL CORD COMPRESSION; TICK BITE;

EID: 0030031134     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389601100102     Document Type: Review

References (76)

1. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(Suppl):S21-S24.
2. van der Meché FGA, Meulstee J, Kleyweg RP: Current diagnostic criteria for Guillain-Barré syndrome, letter. Ann Neurol 1991;30:851-852.
3. Honavar M, Tharakan KJ, Hughes RAC, et al: A clinicopathological study of the Guillain-Barré syndrome: Nine cases and literature review. Brain 1991;114:1245-1269.
4. Beghi E, Kurland LT, Mulder DW, Wiederholt WC: Guillain-Barré syndrome: Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol 1985;42:1053-1057.
5. Gilmartin RC, Ch'ien LT: Guillain-Barré syndrome with hydrocephalus in early infancy. Arch Neurol 1977;34:567-569.
6. Carroll JE, Jedziniak M, Guggenheim MA: Guillain-Barré syndrome: Another cause of the "floppy infant." Am J Dis Child 1977;131:699-700.
7. Al-Qudah AA, Shahar E, Logan WJ, Murphy EG: Neonatal Guillain-Barré syndrome. Pediatr Neurol 1988;4:255-256.
8. Chambers R, MacDermot V: Polyneuritis as a cause of "amyotonia congenita." Lancet 1957;1:397-401.
9. Pasternak JF, Fulling K, Nelson J, Prensky AL: An infant with chronic, relapsing polyneuropathy responsive to steroids. Dev Med Child Neurol 1982;24:505-524.
10. Bradshaw DY, Jones HR Jr: Guillain-Barré syndrome in children: Clinical course, electrodiagnosis, and prognosis. Muscle Nerve 1992;15:500-506.
11. Cole GF, Matthew DJ: Prognosis in severe Guillain-Barré syndrome. Arch Dis Child 1987;62:288-291.
12. Kleyweg RP, van der Meché FGA, Loonen MCB, et al: The natural history of the Guillain-Barré syndrome in 18 children and 50 adults. J Neurol Neurosurg Psychiatry 1989;52:853-856.
13. Mikati MA, DeLong GR: Childhood Guillain-Barré syndrome masquerading as a protracted pain syndrome, letter. Arch Neurol 1985;42:839.
14. Becker WJ, Watters GV, Humphreys P: Fisher syndrome in childhood. Neurology 1981;31:555-560.
15. Bell W, Van Allen M, Blackman J: Fisher syndrome in childhood. Dev Med Child Neurol 1970;12:758-766.
16. Kusunoki S, Chiba A, Kanazawa I: GQ1b antibody in Fisher syndrome and immunohistochemical studies, abstract. Muscle Nerve 1994;17(Suppl 1):S44.
17. Jacobs BC, Endtz HP, van Doorn PA, van der Meché FGA: Serum anti-GQ1b IgG antibodies can specifically bind to Campylobacter jejuni strains from Miller Fisher patients, abstract. Muscle Nerve 1994;17(Suppl 1):S235.
18. Siemes H, Emerich R, Merlin M, Reitter B: Die akute Polyradikuloneuritis (Guillain-Barré Syndrom) im Kindesalter. Klin Padiatr 1983;195:38-44.
19. Winer JB, Hughes RA, Anderson MJ, et al: A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-618.
20. Ropper AH: Campylobacter diarrhea and Guillain-Barré syndrome. Arch Neurol 1988;45:655-656.
21. Low NL, Schneider J, Carter S: Polyneuritis in children. Pediatrics 1958;22:972-990.
22. Paulson GW: The Landry-Guillain-Barré-Strohl syndrome in childhood. Dev Med Child Neurol 1970;12:604-607.
23. Peterman AF, Daly DD, Dion FR, Keith HM: Infectious neuronitis (Guillain-Barré syndrome) in children. Neurology 1959;9: 533-539.
24. Markland LD, Riley HD Jr: The Guillain-Barré syndrome in childhood: A comprehensive review, including observations of 19 additional cases. Clin Pediatr 1967;6:162-170.
25. Nass R, Chutorian A: Dysaesthesias and dysautonomia: A self-limited syndrome of painful dysaesthesias and autonomic dysfunction in childhood. J Neurol Neurosurg Psychiatry 1982; 45:162-165.
26. Arnason BGW, Soliven B: Acute inflammatory demyelinating polyradiculoneuropathy, in Dyck PJ, Thomas PK (eds): Peripheral Neuropathy, 3rd ed, vol 2. Philadelphia, WB Saunders, 1993, pp 1437-1497.
27. Cherington M, Snyder RD: Tick paralysis: Neurophysiologic studies. N Engl J Med 1968;278:95-97.
28. Swift TR, Ignacio OJ: Tick paralysis: Electrophysiologic studies. Neurology 1975;25:1130-1133.
29. Beausoleil JL, Nordgren RE, Modlin JF: Vaccine-associated paralytic poliomyelitis. J Child Neurol 1994;9:334-335.
30. Price L, Gominak S, Raphael SA, et al: Acute demyelinating polyneuropathy in childhood human immunodeficiency virus infection, abstract. Ann Neurol 1990;28:459-460.
31. Donofrio PD, Wilbourn AJ, Albers JW, et al: Acute arsenic intoxication presenting as Guillain-Barré syndrome. Muscle Nerve 1987;10:114-120.
32. Le Quesne PM, McLeod JG: Peripheral neuropathy following a single exposure to arsenic: Clinical course in four patients with electrophysiological and histological studies. J Neurol Sci 1977;32:437-451.
33. Seto DSY, Freeman JM: Lead neuropathy in childhood. Am J Dis Child 1964;107:337-342.
34. Windebank AJ, McCall JT, Dyck PJ: Metal neuropathy, in Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds): Peripheral Neuropathy, 2nd ed, vol 2. Philadelphia, WB Saunders, 1984, pp 2133-2161.
35. Ross AT: Mercuric polyneuropathy with albumino-cytologic dissociation and eosinophilia. JAMA 1964;188:830-831.
36. Swaiman KF, Flagler DG: Mercury poisoning with central and peripheral nervous system involvement treated with penicillamine. J Pediatr 1971;48:639-642.
37. Agocs MM, Etzel RA, Parrish RG, et al: Mercury exposure from interior latex paint. N Engl J Med 1990;323:1096-1101.
38. Davis LE, Standefer JC, Kornfeld M, et al: Acute thallium poisoning: Toxicological and morphological studies of the nervous system. Ann Neurol 1981;10:38-44.
39. Korobkin R, Asbury AK, Sumner AJ, Nielsen SL: Glue-sniffing neuropathy. Arch Neurol 1975;32:158-162.
40. Jenkins RB, Toole JF: Polyneuropathy following exposure to insecticides: Two cases of polyneuropathy with albuminocytologic dissociation in the spinal fluid following exposure to DDD and aldrin and DDT and endrin. Arch Intern Med 1964;113: 691-695.
41. Dirik E, Uysal KM: Organophosphate-induced delayed polyneuropathy, abstract. Pediatr Neurol 1994;11:111.
42. Calderon-Gonzalez R, Rizzi-Hernandez H: Buckthorn polyneuropathy. N Engl J Med 1967;277:69-71.
43. Jones HR Jr: Pediatric electromyography, in Brown WE, Bolton CF (eds): Clinical Electromyography, 2nd ed. Boston, Butterworth, 1993, pp 734-740.
44. Bradshaw DY: Acute pediatric polyneuropathies, in American Association of Electrodiagnostic Medicine Annual Meeting. Course A: Pediatric Electromyography. Rochester, MN, AAEM, 1993, pp 13-21.
45. Jones HR Jr: Pediatric electromyography, in Brown WF, Bolton CF (eds): Clinical Electromyography, 2nd ed. Boston, Butterworth, 1993, pp 704-717.
46. Coker SB: Leigh disease presenting as Guillain-Barré syndrome. Pediatr Neurol 1993;9:61-63.
47. Lowitzsch K, Gutjahr P, Ottes H: Clinical and neurophysiological findings in 47 long-term survivors of childhood malignancies treated with various doses of vincristine, in Canal N, Pozza G (eds): Peripheral Neuropathies. New York, Elsevier/North-Holland Biomedical, 1978, pp 459-465.
48. Jones HR Jr: Pediatric electromyography, in Brown WF, Bolton CF (eds): Clinical Electromyography, 2nd ed. Boston, Butterworth, 1993, p 738.
49. Graff WD, Chance PF, Lensch W, et al: Charcot-Marie-Tooth type IA with 17p11.2-12 duplication predisposes to severe vincristine neuropathy, abstract. Pediatr Neurol 1994;11:103.
50. Amit R, Parker M, Newman G, et al: Guillain-Barré syndrome in an immunosuppressed child, abstract. Pediatr Neurol 1994;11: 107.
51. Banerji NK, Millar JHD: Guillain-Barré syndrome in children, with special reference to serial nerve conduction studies. Dev Med Child Neurol 1972;14:56-63.
52. McKhann GM, Cornblath DR, Ho T, et al: Clinical and electrophysiologic aspects of acute paralytic disease of children and young adults in northern China. Lancet 1991;338:593-597.
53. Wu HS, Liu TC, Lu JL, et al: Clinical and electrophysiologic characteristics of acute flaccid paralysis in Chinese children, abstract. Pediatr Neurol 1994;11:161.
54. Feasby TE, Gilbert JJ, Brown WF, et al: An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109(Pt 6): 1115-1126.
55. Brown WF, Feasby TE: Conduction block and denervation in Guillain-Barré polyneuropathy. Brain 1984;107(Pt 1):219-239.
56. Massaro ME, Arroyo HA, Rodriguez E, et al: Nerve biopsy in severe Guillain-Barré syndrome and inexcitable motor nerves, abstract. Pediatr Neurol 1994;11:146.
57. Rossi LN, Mumenthaler M, Lütschg J, Ludin HP: Guillain-Barré syndrome in children with special reference to the natural history of 38 personal cases. Neuropadiatrie 1976;7:45-51.
58. The Guillain-Barré Syndrome Study Group: Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-1104.
59. Dyck PJ, Kurtzke JF: Plasmapheresis in Guillain-Barré syndrome, editorial. Neurology 1985;35:1105-1107.
60. Mendell JR, Kissel JT, Kennedy MS, et al: Plasma exchange and prednisone in Guillain-Barré syndrome. Neurology 1985;35: 1551-1555.
61. Epstein MA, Sladky JT: The role of plasmapheresis in childhood Guillain-Barré syndrome. Ann Neurol 1990;28:65-69.
62. Lamont PJ, Johnston HM, Berdoukas VA: Plasmapheresis in children with Guillain-Barré syndrome. Neurology 1991;41: 1928-1931.
63. Niparko N, Goldie WD, Mitchell W, et al: The use of plasmapheresis in the management of Guillain-Barré syndrome in pediatric patients, abstract. Ann Neurol 1989;26:448-449.
64. Khatri BO, Flamini JR, Baruah JK, et al: Plasmapheresis with acute inflammatory polyneuropathy. Pediatr Neurol 1990;6: 17-19.
65. Jansen PW, Perkin RM, Ashwal S: Guillain-Barré syndrome in childhood: Natural course and efficacy of plasmapheresis. Pediatr Neurol 1993;9:16-20.
66. Griesemer DA, Johnson MI: Guillain-Barré syndrome and plasmapheresis in childhood. Ann Neurol 1991;29:688.
67. Jones HR Jr, Bradshaw DY: Guillain-Barré syndrome and plasmapheresis in childhood. Ann Neurol 1991;29:688-689.
68. Shanks DE, Lenn NJ: Plasmapheresis associated with a relapsing course in Guillain-Barré syndrome. Pediatr Neurol 1989; 5:189-190.
69. Kleyweg RP, van der Meché FGA, Meulstee J: Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology 1988;38:1639-1641.
70. Shahar E, Murphy EG, Roifman CM: Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome. J Pediatr 1990;116:141-144.
71. Al-Qudah AA: Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood. J Child Neurol 1994;9: 178-180.
72. Lavenstein BL, Shin W, Watkin T, Keller S: Four-year follow-up study of use of IVIg in childhood acute inflammatory demyelinating polyneuropathy (GBS), abstract. Neurology 1994; 44(Suppl 2):A169.
73. Johnston HM, Goodhew PM: Immunoglobulin therapy in Guillain-Barré syndrome, abstract. Pediatr Neurol 1994;11:122.
74. van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group: A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-1129.
75. Hughes RAC, Kadlubowski M, Hufschmidt A: Treatment of acute inflammatory polyneuropathy. Ann Neurol 1981;9(Suppl): 125-133.
76. Ropper AH: The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-1136.